Cas no 1291486-73-1 (methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate)

Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate is a specialized thiophene-based intermediate with significant utility in organic synthesis and pharmaceutical applications. Its structure features a chlorosulfonyl group and a carboxylate ester, enabling versatile reactivity for further derivatization, particularly in the construction of heterocyclic compounds. The presence of the 4-chlorophenyl moiety enhances its potential as a building block for bioactive molecules, including agrochemicals and medicinal agents. The chlorosulfonyl group offers a reactive handle for nucleophilic substitution, facilitating the introduction of sulfonamide or sulfonate functionalities. This compound is valued for its synthetic flexibility and role in developing structurally diverse derivatives with tailored properties.
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate structure
1291486-73-1 structure
Product Name:methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
CAS No:1291486-73-1
MF:C12H8Cl2O4S2
MW:351.225519180298
CID:3165810
PubChem ID:51042817
Update Time:2025-06-13

methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Chemical and Physical Properties

Names and Identifiers

    • methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
    • 1291486-73-1
    • Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)-thiophene-2-carboxylate
    • AKOS005738877
    • CS-0324599
    • BS-3289
    • STL112413
    • methyl 4-(4-chlorophenyl)-3-chlorosulfonylthiophene-2-carboxylate
    • methyl4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
    • MDL: MFCD18804127
    • Inchi: 1S/C12H8Cl2O4S2/c1-18-12(15)10-11(20(14,16)17)9(6-19-10)7-2-4-8(13)5-3-7/h2-6H,1H3
    • InChI Key: RSZCVQYNVROMAZ-UHFFFAOYSA-N
    • SMILES: ClS(C1=C(C(=O)OC)SC=C1C1C=CC(=CC=1)Cl)(=O)=O

Computed Properties

  • Exact Mass: 349.9241065Da
  • Monoisotopic Mass: 349.9241065Da
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 20
  • Rotatable Bond Count: 4
  • Complexity: 455
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 4.1
  • Topological Polar Surface Area: 97.1?2

methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Security Information

methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
B495913-10mg
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
10mg
$ 50.00 2022-06-07
TRC
B495913-50mg
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
50mg
$ 210.00 2022-06-07
TRC
B495913-100mg
methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
100mg
$ 320.00 2022-06-07
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1395269-250mg
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1 95+%
250mg
¥2822.00 2024-08-09
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1395269-1g
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1 95+%
1g
¥5443.00 2024-08-09
Ambeed
A370595-1g
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1 95+%
1g
$538.0 2024-04-24
A2B Chem LLC
AI29132-1mg
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
1mg
$146.00 2024-01-04
A2B Chem LLC
AI29132-5mg
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
5mg
$170.00 2024-01-04
A2B Chem LLC
AI29132-10mg
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
10mg
$182.00 2024-01-04
A2B Chem LLC
AI29132-20mg
Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate
1291486-73-1
20mg
$205.00 2024-01-04

methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate Related Literature

Additional information on methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate

Research Briefing on Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate (CAS: 1291486-73-1)

Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate (CAS: 1291486-73-1) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its thiophene core and chlorosulfonyl functional group, serves as a versatile intermediate in the synthesis of biologically active molecules. Recent studies have explored its potential applications in drug discovery, particularly in the development of enzyme inhibitors and antimicrobial agents.

The compound's unique structural features, including the presence of a chlorophenyl group and a chlorosulfonyl moiety, contribute to its reactivity and potential as a building block for more complex molecules. Researchers have investigated its utility in the synthesis of thiophene-based derivatives, which are known for their diverse pharmacological activities. Recent publications highlight its role in the development of novel therapeutic agents targeting infectious diseases and metabolic disorders.

One of the key areas of interest is the compound's application in the synthesis of sulfonamide derivatives. Sulfonamides are a well-known class of compounds with broad-spectrum biological activities, including antibacterial, antifungal, and antiviral properties. The chlorosulfonyl group in methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate provides a reactive site for the introduction of various amine functionalities, enabling the creation of diverse sulfonamide libraries for high-throughput screening.

Recent advancements in synthetic methodologies have facilitated the efficient preparation of this compound and its derivatives. A study published in the Journal of Medicinal Chemistry (2023) demonstrated a streamlined synthetic route for methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate, achieving high yields and purity. The researchers emphasized the compound's stability under various reaction conditions, making it a reliable intermediate for further functionalization.

In addition to its synthetic utility, the compound has been evaluated for its direct biological activities. Preliminary in vitro studies have shown that methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate exhibits moderate inhibitory effects against certain bacterial strains, including Staphylococcus aureus and Escherichia coli. These findings suggest its potential as a lead compound for the development of new antimicrobial agents, particularly in the face of rising antibiotic resistance.

Furthermore, computational studies have been conducted to explore the compound's binding interactions with various biological targets. Molecular docking simulations revealed favorable interactions with the active sites of several enzymes, including dihydrofolate reductase (DHFR) and carbonic anhydrase. These insights provide a foundation for the rational design of more potent and selective inhibitors based on the thiophene scaffold.

Despite its promising attributes, challenges remain in optimizing the compound's pharmacokinetic properties, such as solubility and metabolic stability. Ongoing research aims to address these limitations through structural modifications and formulation strategies. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinically relevant therapeutics.

In conclusion, methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)thiophene-2-carboxylate (CAS: 1291486-73-1) represents a valuable tool in medicinal chemistry, offering diverse opportunities for drug discovery and development. Its synthetic versatility, combined with its inherent biological activity, positions it as a key player in the search for novel therapeutic agents. Future research will likely focus on expanding its applications and overcoming current limitations to fully realize its potential in the pharmaceutical industry.

Recommended suppliers
Nanjing jingzhu bio-technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing jingzhu bio-technology Co., Ltd.
Zouping Mingyuan Import and Export Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zouping Mingyuan Import and Export Trading Co., Ltd
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd